As the production of endogenous adiponectin is impaired as an effect of obesity and related pathologies, a practical therapeutic approach is to use pharmacological or dietary interventions to restore the capacity of adipose tissue in secreting adiponectin. The gene discussed is ADIPOQ; the disease is obesity due to melanocortin 4 receptor deficiency.